GUEPRATTE S[au] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2004	3
2005	1
2023	0

Page 1

Tissue expression and serum levels of the oncoprotein HER-2/neu in 157 primary breast tumours.

Pallud C, Guinebretiere JM, Guepratte S, Hacene K, Neumann R, Carney W, Pichon MF. Pallud C, et al. Among authors: guepratte s. Anticancer Res. 2005 Mar-Apr;25(2B):1433-40. Anticancer Res. 2005. PMID: 15865102 Free article.

Longitudinal changes in serum HER-2/neu oncoprotein levels in trastuzumab-treated metastatic breast cancer patients.

Bethune-Volters A, Labroquere M, Guepratte S, Hacene K, Neumann R, Carney W, Pichon MF. Bethune-Volters A, et al. Among authors: guepratte s. Anticancer Res. 2004 Mar-Apr;24(2C):1083-9. Anticancer Res. 2004. PMID: 15154627 Free article.

Serum HER-2 extracellular domain: relationship with clinicobiological presentation and prognostic value before and after primary treatment in 701 breast cancer patients.

Saghatchian M, Guepratte S, Hacene K, Neumann R, Floiras JL, Pichon MF. Saghatchian M, et al. Among authors: guepratte s. Int J Biol Markers. 2004 Jan-Mar;19(1):14-22. doi: 10.1177/172460080401900102. Int J Biol Markers. 2004. PMID: 15077922 Free article.

Serum HER-2 extracellular domain (ECD) before the first metastasis in 128 breast cancer patients.

Pichon MF, Hacene K, Guepratte S, Neumann R. Pichon MF, et al. Among authors: guepratte s. Clin Lab. 2004;50(3-4):163-70. Clin Lab. 2004. PMID: 15074470

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results